{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:39:15Z","timestamp":1777437555179,"version":"3.51.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Neuroendocrine neoplasms (NEN) originate in many body parts, with 70% reported from the gastrointestinal system, 25% from the lungs. NENs of the breast account for\u2005&amp;lt;\u20051% of all NENs. The primary breast NEN nomenclature was changed in the most recent World Health Organization classification in 2019. Since the pathological classification has changed several times, there are no definitive data on treatment management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this study, patients followed up in our clinic were pathologically reevaluated according to the latest classification.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The clinical characteristics, treatments, recurrence, and survival status of 36 patients with early stage primary breast NEN were examined. A statistically significant difference was determined in respect of overall survival (OS) for the Eastern Cooperative Oncology Group Performance Score (ECOG PS), type of surgery, age\u2005\u2265\u200570 years, PR positivity, and tumor size. A low ECOG PS, younger age, breast-conserving surgery (BCS), and small tumor diameter were associated with better survival. A low ECOG PS, early stage, BCS, and fewer than 4 malignant lymph nodes were associated with better disease-free survival. All the patients in this study were at an early stage and were treated for typical breast cancer, although some patients diagnosed with neuroendocrine carcinoma (NEC) received cisplatin and etoposide treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In our study, the prognosis of breast NEN patients was better than the literature data. Maybe the prognosis of patients evaluated as breast NEN according to the new classification is better than the older classification groups.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyaf171","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T21:46:23Z","timestamp":1751319983000},"source":"Crossref","is-referenced-by-count":1,"title":["Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8575-5477","authenticated-orcid":false,"given":"Seda","family":"Sali","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Bursa City Hospital , 16110 Nilufer ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2079-3350","authenticated-orcid":false,"given":"Mursel","family":"Sali","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1591-3323","authenticated-orcid":false,"given":"Burcu","family":"Caner","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Aydin Ataturk State Hospital , 09100 Aydin ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7537-1699","authenticated-orcid":false,"given":"Birol","family":"Ocak","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital , 16310 Yildirim ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-8082","authenticated-orcid":false,"given":"Eyup","family":"Coban","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-6587","authenticated-orcid":false,"given":"Alper","family":"Coskun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-7649","authenticated-orcid":false,"given":"Mine","family":"Ozsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-3471","authenticated-orcid":false,"given":"Sibel","family":"Oyucu Orhan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Bursa City Hospital , 16110 Nilufer ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-0870","authenticated-orcid":false,"given":"Ahmet Bilgehan","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3669-6391","authenticated-orcid":false,"given":"Adem","family":"Deligonul","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-0889","authenticated-orcid":false,"given":"Erdem","family":"Cubukcu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-0515","authenticated-orcid":false,"given":"Sahsine","family":"Tolunay","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-5340","authenticated-orcid":false,"given":"Turkkan","family":"Evrensel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, School of Medicine, Bursa Uludag University , 16059 Gorukle ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2025082702462080000_CIT0001","first-page":"24","article-title":"On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (gelatinosum) mammae","volume":"73","author":"Feyrter","year":"1963","journal-title":"Frankf Z Pathol"},{"key":"2025082702462080000_CIT0002","first-page":"155","article-title":"Neuroendocrine neoplasms: introduction","volume":"2","author":"Rakha","year":"2019","journal-title":"WHO Classification Tumours Breast Tumours."},{"key":"2025082702462080000_CIT0003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000362430","article-title":"Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany","volume":"37","author":"H\u00f6rsch","year":"2014","journal-title":"Oncol Res Treat"},{"key":"2025082702462080000_CIT0004","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41379-021-00736-7","article-title":"Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification","volume":"34","author":"Tsang","year":"2021","journal-title":"Mod Pathol"},{"key":"2025082702462080000_CIT0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 WHO classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"2025082702462080000_CIT0006","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2025082702462080000_CIT0007","doi-asserted-by":"publisher","first-page":"e1318","DOI":"10.1634\/theoncologist.2020-0081","article-title":"The clinical significance of neuroendocrine features in invasive breast carcinomas","volume":"25","author":"Lai","year":"2020","journal-title":"Oncologist"},{"key":"2025082702462080000_CIT0008","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-021-06099-6","article-title":"Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast","volume":"186","author":"Yang","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2025082702462080000_CIT0009","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1245\/s10434-022-12123-w","article-title":"Primary breast neuroendocrine tumors: an analysis of the national cancer database","volume":"29","author":"Martinez","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2025082702462080000_CIT0010","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/modpathol.2017.107","article-title":"Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast","volume":"31","author":"Lavigne","year":"2018","journal-title":"Mod Pathol"},{"key":"2025082702462080000_CIT0011","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/modpathol.3880387","article-title":"Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women","volume":"14","author":"Sapino","year":"2001","journal-title":"Mod Pathol"},{"key":"2025082702462080000_CIT0012","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2011.04.001","article-title":"Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons","volume":"70","author":"Kwon","year":"2011","journal-title":"Neuron"},{"key":"2025082702462080000_CIT0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"2025082702462080000_CIT0014","doi-asserted-by":"crossref","first-page":"111726","DOI":"10.1016\/j.mce.2022.111726","article-title":"Synaptophysin and chromogranin A expression analysis in human tumors","volume":"555","author":"Uhlig","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"2025082702462080000_CIT0015","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/nejmra021405","article-title":"The chromogranin\u2013secretogranin family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N Engl J Med"},{"key":"2025082702462080000_CIT0016","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/cancers14010196","article-title":"Neuroendocrine neoplasms of the breast: the latest WHO classification and review of the literature","volume":"14","author":"Ozaki","year":"2021","journal-title":"Cancers"},{"key":"2025082702462080000_CIT0017","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2407-14-147","article-title":"Invasive neuroendocrine carcinoma of the breast: a population based study from the surveillance, epidemiology and end results (SEER) database","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"2025082702462080000_CIT0018","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-11-128","article-title":"Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature","volume":"11","author":"Angarita","year":"2013","journal-title":"World J Surg Oncol"},{"key":"2025082702462080000_CIT0019","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.23.01994","article-title":"Adjuvant abemaciclib plus endocrine therapy for hormone receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative, high-risk early breast cancer: results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyaf171\/63630166\/oyaf171.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/8\/oyaf171\/63630166\/oyaf171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/8\/oyaf171\/63630166\/oyaf171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:46:28Z","timestamp":1756277188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf171\/8178844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf171","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8]]},"article-number":"oyaf171"}}